Chelsea Reinhold

Chelsea Reinhold has worked for a number of companies since 2011. Chelsea began their career as a Research Assistant III at Beth Israel Deaconess Medical Center in 2011. In 2014, they joined Augmenix, Inc. as a Quality Assurance Specialist, and then moved up to the roles of Regulatory Affairs Associate, Clinical Research Associate, and Senior Clinical Project Manager. In 2019, they joined Boston Scientific as a Clinical Strategy Manager and Instylla as a Sr. Clinical Project Manager. In 2020, they joined PanTher Therapeutics as a Clinical Operations Support. Most recently, they are the Owner of CBR Consulting.

Chelsea Reinhold obtained a Bachelor of Science (BS) in Molecular and Cellular Biology from the University of Connecticut between 2007 and 2011. Chelsea then went on to pursue a Master of Science (MS) in Clinical Research at the Massachusetts College of Pharmacy and Health Sciences, which they completed in 2015.